stalled weight loss on tirzepatide Before and after results: what real transformations look like and what determines success Switching from tirzepatide to semaglutide:

Results: Of 783 individuals who started the 36 week, open-label, lead-in treatment period, approximately 7% (n = 53) withdrew due to side effects, while 670 achieved maximum tolerated dose of 15 mg subq weekly (93%) or 10 mg subq weekly (7%)

[accessed 1 March 2024] Eli Lilly and Company 2021

5mg vial reconstitution The most practical volume for a 5mg vial is 1mL of bacteriostatic water , creating a 5mg/mL concentration

Everything about this program has been great so far, and Im hopeful and excited to keep going

These figures suggest promise, but the research continues

For consumers, BBB non-accreditation should be one factor among many in evaluating a company